BioneXX, a portfolio company of FINEXX, acquires BeLive, a US-based nutritional supplement company Learn more FOSTEC & CompanyTransaktionenBioneXX, a portfolio company of FINEXX, acquires BeLive, a US-based nutritional supplement company The Target Founded in 2017, BeLive had already increased its sales by 165 percent last year and is a top seller on the Amazon marketplace with two products for Nutraceutical Gummies. BeLive’s products are designed to meet mineral and trace element needs. As the market-leading holding company for certified organic & biological nutritional supplements, BioneXX now plans to expand the trend to the German market and add four new products to its range. The Transaction This acquisition marks BioneXX’s fourth investment by shareholder FINEXX and its second investment with the support of boutique strategy consulting firm FOSTEC & Company. As one of the fastest growing companies in Europe, FOSTEC & Company advised the client FINEXX on the transaction with a commercial due diligence and a comprehensive analysis of the digital value chain and e-commerce activities. “We have been able to achieve gratifying growth within the BioneXX Group over the past two years. The analyses within the scope of the CDD as well as the developed growth strategy of FOSTEC & Company have supported us significantly in this regard. This has enabled us to expand BioneXX as an international competitor, gain a sustainable foothold in the USA in particular, while minimizing risks during the transaction,” says Matthias Heining, Managing Director of FINEXX GmbH about the cooperation with FOSTEC & Company. Industries: Food & Nutrition Visit Website